The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCBX.L Regulatory News (CBX)

  • There is currently no data for CBX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Warrants

10 May 2023 17:48

RNS Number : 0110Z
Cellular Goods PLC
10 May 2023
 

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014, as retained as part of the law of England and Wales. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

 

10 May 2023

 

Cellular Goods PLC

 

("Cellular Goods" or "the Company")

Grant of Warrants

Cellular Goods (LSE: CBX) a UK-based skincare and wellness company providing premium consumer products formulated with lab-produced cannabinoids, announces that it has granted Misha Sher, the Company's Non-Executive Director, a total of 2,000,000 warrants to subscribe for new ordinary shares of £0.001 each ('Warrants'). The Warrants are exercisable at 0.97 pence per ordinary share.

One third of the warrants will vest on 10 May 2024 with the remaining two thirds vesting in 24 equal monthly instalments thereafter. The Warrants have an exercise period from the date of grant to 10 May 2028.

Following the issue of the Warrants, the Company has a total of 59,460,000 warrants in issue.

 

For further information please contact:

Cellular Goods

Darcy Taylor

Chairman and interim CEO

Neil Thapar

Investor Relations

via Tancredi +44 207 887 7633

 

+44 787 645 5323

First Sentinel Corporate Finance

Corporate Broker & Advisor

Brian Stockbridge

 

+44 7876 888 011

Novum Securities

 

Corporate Broker

Colin Rowbury

Jon Belliss

 

 

+44 207 399 9427

Tancredi Intelligent Communication

Media Relations

Helen Humphrey

Charlie Hobbs

cellulargoods@tancredigroup.com

 

+44 744 922 6720

+44 789 755 7112

 

About Cellular Goods PLC:

Cellular Goods develops and markets premium quality skincare and wellness products based on proprietary formulations incorporating biosynthetic lab-made cannabinoids. Our branded products are efficacy-led and research-backed and available online in the UK and US. The Company is incorporated in the UK and listed on the Main Market of the London Stock Exchange. For more information, visit www.cellular-goods.com.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Misha Sher

2.

Reason for the Notification

a)

Position/status

Non-executive director

b)

Initial notification / Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Cellular Goods PLC

b)

LEI

213800IXPX4Z2MKX2U28

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares of £0.001 each

ISIN

 ISIN: GB00BK964W87

b)

Nature of the transaction

Grant of warrants over 2,000,000 ordinary shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Exercise price of 0.97 pence per Ordinary Share

2,000,000

Ordinary Shares

d)

Aggregated information:

· Aggregated volume

· Price

 

2,000,000 Ordinary Shares

Exercise price of 0.97 pence per Ordinary Share

e)

Date of the transaction

10th May 2023

f)

Place of the Transaction

Outside a trading venue

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHQBLFFXELZBBE
Date   Source Headline
13th Mar 20097:00 amPRNIssue of Equity
30th Jan 20099:06 amPRNTotal Voting Rights
29th Dec 20087:00 amPRNIssue of Equity
11th Dec 20084:31 pmPRNAlteration to Loan Notes
3rd Dec 20081:13 pmPRNChange of Adviser
19th Nov 20087:00 amPRNHalf-yearly Report
6th Aug 200812:58 pmPRNResult of General Meeting
6th Aug 200812:55 pmPRNDirectorate Changes
6th Aug 200812:52 pmPRNResult of AGM
11th Jul 20081:09 pmPRNNotice of General Meeting
3rd Jul 200812:34 pmPRNDirector/PDMR Dealing
24th Jun 20087:00 amPRNFinal Results
7th Apr 200811:47 amPRNAdviser change of name
28th Mar 20084:03 pmPRNStatement re Dual Listing
20th Mar 20087:00 amPRNDirector/PDMR Shareholding
29th Feb 20087:30 amPRNTotal Voting Rights
25th Feb 20087:00 amPRNFurther re Acquisition
14th Feb 200811:10 amPRNFurther re issue of equity
12th Feb 20087:00 amPRNIssue of Equity
11th Feb 20088:41 amPRNChange of Adviser
7th Feb 200811:18 amPRNResult of EGM
21st Jan 20082:37 pmRNSSchedule 1-Cubus Lux plc
15th Jan 20087:30 amRNSRestoration - Cubus Lux plx
15th Jan 20087:30 amPRNPosting of Admission Document
24th Dec 200711:00 amRNSSuspension - Cubus Lux plc
24th Dec 200711:00 amPRNExercise of Option and Temporary Suspension
26th Nov 20077:00 amPRNHalf-yearly Report
1st Oct 20073:14 pmPRNExtension of option agreements
28th Sep 20077:30 amPRNTotal Voting Rights
24th Sep 200711:09 amPRNAppointment of Joint Broker
21st Sep 20077:00 amPRNDirector/PDMR Shareholding
31st Aug 20072:45 pmPRNAGM Statement
17th Aug 20073:59 pmPRNAIM Rule 26 - Company Website
8th Aug 200712:46 pmPRNFurther re: Board Appointments
13th Jul 20077:30 amPRNExtension of option agreements
26th Jun 20077:00 amPRNFinal Results
21st May 200712:00 pmRNSRestoration - Cubus Lux plc
21st May 200712:00 pmRNSChange of Adviser
18th May 20074:41 pmRNSDirectorate Change
15th May 20077:02 amRNSSuspension - Cubus Lux plc
15th May 20077:02 amRNSStatement re. Suspension
3rd May 20072:00 pmRNSPlacing
19th Mar 20077:01 amRNSAgreement
13th Mar 200710:18 amRNSOption Agreement
5th Feb 20077:00 amRNSRe Agreement
24th Jan 20077:01 amRNSTotal Voting Rights
15th Jan 20077:00 amRNSPlacing
3rd Jan 200710:50 amRNSNew Accounting Ref Date
27th Dec 20068:56 amRNSTotal Voting Rights
27th Dec 20068:56 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.